|
rdfs:label
|
"agalsidasa beta"@ca
"agalsidasa beta"@gl
"agalsidase beta"@en
"agalsidase bêta"@fr
"beta-agalsidase"@pt
|
|
skos:altLabel
|
"Agalsidase alfa"@en
"Alpha-D- galactoside galactohydrolase"@en
"Alpha-D-galactosidase A"@en
"Alpha-galactosidase A precursor"@en
"Melibiase"@en
"agalsidase alfa"@fr
|
|
schema:description
|
"chemická sloučenina"@cs
"chemische Verbindung"@de
"chemische verbinding"@nl
"component quimic"@oc
"compost químic"@ca
"composto chimico"@it
"composto químico"@gl
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"konposatu kimiko"@eu
"medicamento"@pt
"pharmaceutical drug"@en
"związek chemiczny"@pl
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
|
|
schema:dateModified
|
"2026-11-04T17:27:11+00:00"^^xsd:dateTime
|
|
schema:version
|
2564772919
|
|
wikibase:identifiers
|
9
|
|
wikibase:sitelinks
|
0
|
|
wikibase:statements
|
18
|
|
p:P1552
|
wd:statement/Q20801779-CC0281FD-056C-4BB8-8B8B-C1C1C33A3953
|
|
p:P2115
|
wd:statement/Q20801779-61E97A98-9A6A-4562-912B-6F80E26C7B24
|
|
p:P2175
|
wd:statement/Q20801779-0504DB73-BA42-41AE-8C18-6B451C92A597
|
|
wd:statement/Q20801779-53DC75D2-700B-4563-ADF7-79B7B9B86651
|
|
p:P231
|
wd:statement/Q20801779-CC1EA3E7-3631-4700-BEB6-ACB978CB5C53
|
|
p:P267
|
wd:statement/Q20801779-4454F9A5-CBCF-40B4-A145-4184BEA7E123
|
|
p:P279
|
wd:statement/Q20801779-E34A26DD-2CB8-45CE-AB7E-A0E21781CC97
|
|
p:P31
|
wd:statement/Q20801779-71E6E179-6D1B-4511-8719-3F7BE698E514
|
|
p:P3117
|
wd:statement/Q20801779-2DB9FE8C-C5ED-4E8C-A101-558341CFAB0B
|
|
p:P3345
|
wd:statement/Q20801779-8864E616-A546-42CD-981C-DD34AB0D2E56
|
|
p:P366
|
wd:statement/Q20801779-D0C352A7-D452-4583-BE8D-CBA3E3519854
|
|
p:P3780
|
wd:statement/Q20801779-3FF69AAA-B261-490D-B11B-8CA28D042127
|
|
wd:statement/Q20801779-BCB723EB-AB76-4E15-8920-9083347EA5B6
|
|
p:P4250
|
wd:statement/Q20801779-6759EECB-7787-4D18-A25F-C1D301730B7E
|
|
p:P592
|
wd:statement/Q20801779-18BC0FDC-515F-4EFA-83AF-7AE13A370613
|
|
p:P652
|
wd:statement/Q20801779-2908E95F-775A-4AC4-A9E7-017DAFF29046
|
|
wd:statement/Q20801779-A7F9C0D9-46FA-4B98-B78A-2E1F51CE2B7F
|
|
p:P715
|
wd:statement/Q20801779-15145562-4B14-4DEA-BD26-2D73B7550EFE
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000148806>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL2108888>
|
|
wdt:P1552
|
biopharmaceutical
|
|
wdt:P2115
|
"N0000148806"
|
|
wdt:P2175
|
lipid storage disease
|
|
Fabry disease
|
|
wdt:P231
|
"104138-64-9"
|
|
wdt:P267
|
"A16AB04"
|
|
wdt:P279
|
alpha-glucosidase
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID80883136"
|
|
wdt:P3345
|
"338817"
|
|
wdt:P366
|
medication
|
|
wdt:P3780
|
Fabrazyme
|
|
Replagal
|
|
wdt:P4250
|
5.0^^xsd:decimal
|
|
wdt:P592
|
"CHEMBL2108888"
|
|
wdt:P652
|
"2HLC17MX9G"
|
|
"RZD65TSM9U"
|
|
wdt:P715
|
"DB00103"
|